OP Asset Management Ltd Invests $1.20 Million in The Clorox Company $CLX

OP Asset Management Ltd purchased a new stake in The Clorox Company (NYSE:CLX) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 11,575 shares of the company’s stock, valued at approximately $1,200,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Vermillion & White Wealth Management Group LLC bought a new stake in Clorox in the third quarter worth approximately $25,000. Darwin Wealth Management LLC bought a new position in shares of Clorox during the 2nd quarter valued at $29,000. Caitlin John LLC lifted its stake in shares of Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after purchasing an additional 253 shares during the last quarter. Ameriflex Group Inc. lifted its stake in shares of Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares during the last quarter. Finally, Vision Financial Markets LLC boosted its holdings in Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 0.5%

Clorox stock opened at $97.10 on Tuesday. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The firm has a market capitalization of $11.74 billion, a PE ratio of 15.76, a PEG ratio of 0.51 and a beta of 0.56. The business’s 50-day simple moving average is $94.57 and its 200-day simple moving average is $104.42.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts forecast that The Clorox Company will post 5.61 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on CLX. UBS Group cut their target price on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. Wells Fargo & Company cut their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. Jefferies Financial Group reduced their target price on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. Finally, The Goldman Sachs Group reiterated a “sell” rating and set a $83.00 price target on shares of Clorox in a report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average target price of $103.40.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the stock in a transaction dated Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.